Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

Completed · Phase 2

Conditions studied: Primary Open Angle Glaucoma, Ocular Hypertension

In brief

Evaluating the safety and tolerability of QLS-101 versus timolol maleate ophthalmic solution in glaucoma or ocular hypertension.

Key facts

Study ID

NCT04830397

Run by

Qlaris Bio, Inc.

People needed

84

Starts

2021-03-31

Expected to finish

2022-02-17

Last updated by the study team

2025-01-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Visual acuity +1.0 logMAR or better
• Willing to give informed consent
• Ability to washout from current intraocular pressure lowering medications -

You may not qualify if…

• Severe glaucomatous damage
• Previous glaucoma intraocular or laser surgery
• Refractive surgery
• Ocular infection or inflammation

Where it is running

• Dixon Eye Care — Albany, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.